Immune Mechanisms in Inflammatory Anemia
Maintaining the correct number of healthy red blood cells (RBCs) is critical for proper oxygenation of tissues throughout the body. Therefore, RBC homeostasis is a tightly controlled balance between RBC production and RBC clearance, through the processes of erythropoiesis and macrophage hemophagocytosis, respectively. However, during the inflammation associated with infectious, autoimmune, or inflammatory diseases this homeostatic process is often dysregulated, leading to acute or chronic anemia. In each disease setting, multiple mechanisms typically contribute to the development of inflammatory anemia, impinging on both sides of the RBC production and RBC clearance equation. These mechanisms include both direct and indirect effects of inflammatory cytokines and innate sensing. Here, we focus on common innate and adaptive immune mechanisms that contribute to inflammatory anemias using examples from several diseases, including hemophagocytic lymphohistiocytosis/macrophage activation syndrome, severe malarial anemia during Plasmodium infection, and systemic lupus erythematosus, among others.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Annual review of immunology - 41(2023) vom: 26. Apr., Seite 405-429 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Canny, Susan P [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anemia |
---|
Anmerkungen: |
Date Completed 03.05.2023 Date Revised 26.07.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1146/annurev-immunol-101320-125839 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35260249X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35260249X | ||
003 | DE-627 | ||
005 | 20231226054113.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1146/annurev-immunol-101320-125839 |2 doi | |
028 | 5 | 2 | |a pubmed24n1175.xml |
035 | |a (DE-627)NLM35260249X | ||
035 | |a (NLM)36750316 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Canny, Susan P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immune Mechanisms in Inflammatory Anemia |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.05.2023 | ||
500 | |a Date Revised 26.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Maintaining the correct number of healthy red blood cells (RBCs) is critical for proper oxygenation of tissues throughout the body. Therefore, RBC homeostasis is a tightly controlled balance between RBC production and RBC clearance, through the processes of erythropoiesis and macrophage hemophagocytosis, respectively. However, during the inflammation associated with infectious, autoimmune, or inflammatory diseases this homeostatic process is often dysregulated, leading to acute or chronic anemia. In each disease setting, multiple mechanisms typically contribute to the development of inflammatory anemia, impinging on both sides of the RBC production and RBC clearance equation. These mechanisms include both direct and indirect effects of inflammatory cytokines and innate sensing. Here, we focus on common innate and adaptive immune mechanisms that contribute to inflammatory anemias using examples from several diseases, including hemophagocytic lymphohistiocytosis/macrophage activation syndrome, severe malarial anemia during Plasmodium infection, and systemic lupus erythematosus, among others | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a anemia | |
650 | 4 | |a hemophagocyte | |
650 | 4 | |a hemophagocytic lymphohistiocytosis | |
650 | 4 | |a inflammation | |
650 | 4 | |a malaria | |
650 | 4 | |a sickle cell anemia | |
700 | 1 | |a Orozco, Susana L |e verfasserin |4 aut | |
700 | 1 | |a Thulin, Natalie K |e verfasserin |4 aut | |
700 | 1 | |a Hamerman, Jessica A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annual review of immunology |d 1993 |g 41(2023) vom: 26. Apr., Seite 405-429 |w (DE-627)NLM013568523 |x 1545-3278 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2023 |g day:26 |g month:04 |g pages:405-429 |
856 | 4 | 0 | |u http://dx.doi.org/10.1146/annurev-immunol-101320-125839 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2023 |b 26 |c 04 |h 405-429 |